首页 | 本学科首页   官方微博 | 高级检索  
     

IFN-α2a对多发性硬化患者外周血中免疫抑制因子IL-10的影响
引用本文:刘松岩,隋宝珍,等.IFN-α2a对多发性硬化患者外周血中免疫抑制因子IL-10的影响[J].粉末涂料与涂装,2001,14(1):60-61.
作者姓名:刘松岩  隋宝珍
作者单位:[1]白求恩医科大学第三临床学院神经内科,长春130031 [2]长春生物制品研究所,长春130062
摘    要:目的观察重组人干扰素α-2a对MS的治疗效果,探讨其治疗机理。方法采用ELISA夹心法检 测22例MS患者治疗前后血清中IL-10浓度,结合临床疗效进行对比分析。结果重组人干扰素α-2a治疗组患者 血清中IL-10浓度明显增高,临床症状明显改善,与对照组比较差异有显著意义。结论重组人干扰素IFN-α2a可 提高MS患者体内IL-10水平,对MS有良好疗效。

关 键 词:干扰素  多发性硬化  白细胞介素
修稿时间:2000年4月19日

Influence of IFN-α2a on Immuosuppressive Cytokine IL-10 in Peripheral Blood of Patients with Multiple Sclerosis
LIU Songyan,WANG Xiaomei et al.Influence of IFN-α2a on Immuosuppressive Cytokine IL-10 in Peripheral Blood of Patients with Multiple Sclerosis[J].Chinese Journal of Biologicals,2001,14(1):60-61.
Authors:LIU Songyan  WANG Xiaomei
Abstract:Objective To observe the curative effect of IFN-α2a on multiple sclerosis and explore the mechanism of the drug.Methods The IL-10 concentrations in the sera of 22 patients with multiple sclerosis before and after treatment were detected by sandwich ELISA and compared.Results The IL-10 concentrations in the sera of patients treated with IFN-α2a were significantly higher than those of control group,and the clinical symptoms of them were significantly improved.Conclusion IFN-α2a can improve the IL-10 level of patients with multiple sclerosis and treat the disease through anti-inflammatory and immunoregulatory mechanisms.
Keywords:IFN-α2a  Multiple sclerosis  IL-10
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号